Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eli Lilly and other ETFs, options, and stocks.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
43,000
Employees43,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
43,000
Employees43,000

LLY Key Statistics

Market cap
690.28B
Market cap690.28B
Price-Earnings ratio
125.19
Price-Earnings ratio125.19
Dividend yield
0.65%
Dividend yield0.65%
Average volume
2.31M
Average volume2.31M
High today
$750.00
High today$750.00
Low today
$722.11
Low today$722.11
Open price
$749.01
Open price$749.01
Volume
3.51M
Volume3.51M
52 Week high
$800.78
52 Week high$800.78
52 Week low
$369.76
52 Week low$369.76

LLY News

Yahoo Finance 22h
Eli Lilly Shares Show Healthy Rise - Yahoo Finance

Eli Lilly Stock Loved by Big Money Institutional volumes reveal plenty. Over the past year, our proprietary signals indicate LLY has enjoyed a surge in demand....

Eli Lilly Shares Show Healthy Rise - Yahoo Finance
Benzinga 23h
Exploring The Competitive Space: Eli Lilly and Co Versus Industry Peers In Pharmaceuticals - Eli Lilly an - Benzinga

Loading... Loading... Amidst today's fast-paced and highly competitive business environment, it is crucial for investors and industry enthusiasts to conduct co...

Exploring The Competitive Space: Eli Lilly and Co Versus Industry Peers In Pharmaceuticals - Eli Lilly an - Benzinga
Investor's Business Daily 2d
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?

Eli Lilly (LLY) stock briefly retook its 50-day line in mid-April after its weight-loss drug, tirzepatide, led to fewer nighttime incidents in people with sleep...

Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?

Analyst ratings

72%

of 29 ratings
Buy
72.4%
Hold
20.7%
Sell
6.9%

More LLY News

NBC News 2d
As Zepbound shortage grows, Eli Lilly says no immediate end is in sight - NBC News

Create your free profile or log in to save this article Create your free profile or log in to save this article Despite Eli Lilly’s assurances about an ample...

As Zepbound shortage grows, Eli Lilly says no immediate end is in sight - NBC News
Yahoo Finance 2d
The Zacks Analyst Blog Highlights Eli Lilly, Linde, Caterpillar, Salesforce, and Wells Fargo - Yahoo Finance

For Immediate Release Chicago, IL – April 18, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research a...

The Zacks Analyst Blog Highlights Eli Lilly, Linde, Caterpillar, Salesforce, and Wells Fargo - Yahoo Finance
Yahoo Finance 2d
Metsera, a well-funded obesity drug startup, sees chance to challenge Lilly, Novo - Yahoo Finance

Dive Brief: Metsera, a richly funded biotechnology startup, launched Thursday with a portfolio of weight loss drugs the company claims could eventually compete...

Metsera, a well-funded obesity drug startup, sees chance to challenge Lilly, Novo - Yahoo Finance
Yahoo Finance 3d
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank - Yahoo Finance

For both the biotech and pharmaceutical industries, what happens in the laboratory is critical to success (or failure, on the flip side). Some good news from a...

Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank - Yahoo Finance
Yahoo Finance 3d
Top Research Reports for Eli Lilly, Linde & Caterpillar - Yahoo Finance

Wednesday, April 17, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports...

Top Research Reports for Eli Lilly, Linde & Caterpillar - Yahoo Finance
Investor's Business Daily 3d
Stocks Fall But S&P 500 Holds Key Level; Eli Lilly, Itron, GOOGL In Focus - Video - IBD - Investor's Business Daily

Apr 17, 2024|04:31 PM ET|ALISSA CORAM, KEN SHREVE The 10-year Treasury yield dropped 7 basis points to around 4.59%, but sellers still hit growth stocks hard....

Stocks Fall But S&P 500 Holds Key Level; Eli Lilly, Itron, GOOGL In Focus - Video - IBD - Investor's Business Daily
Fox Business 3d
Eli Lilly's weight loss drug reduces sleep apnea, study shows - Fox Business

Eli Lilly's weight loss-related drug Zepbound could potentially be used to reduce the severity of sleep apnea in adults with obesity, according to a recent stud...

Eli Lilly's weight loss drug reduces sleep apnea, study shows - Fox Business
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.